Helen Hochstetler Selected Research

Apolipoproteins

1/2014

Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Helen Hochstetler Research Topics

Disease

4	Dementia (Dementias) 01/2016 - 01/2014
4	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 01/2014
3	Cognitive Dysfunction 01/2016 - 01/2014
2	Migraine Disorders (Migraine) 09/2020 - 01/2020

Drug/Important Bio-Agent (IBA)

3	Amyloid (Amyloid Fibrils)IBA 01/2016 - 01/2014
2	florbetapirIBA 01/2016 - 01/2014
1	ErgotaminesIBA 09/2020
1	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 09/2020
1	Analgesics (Analgesic Drugs)IBA 09/2020
1	Serotonin (5 Hydroxytryptamine)IBA 09/2020
1	Tryptamines (Triptans)IBA 09/2020
1	Propranolol (Inderal)FDA LinkGeneric 01/2020
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 01/2020
1	lasmiditanIBA 01/2020
1	5-HT1F Serotonin ReceptorIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2014
1	ApolipoproteinsIBA 01/2014
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2014

Therapy/Procedure

1	Therapeutics 09/2020
1	Investigational Therapies (Experimental Therapy) 01/2014